Clear. 45.4   F New York
AI-Powered News Summarizer
Top Stories

Berlin police deploy water cannon as protesters march against Covid-19 restrictions

November 18, 2020. Summarized by summa-bot.

Police officers block a road between the Brandenburg Gate and the Reichstag building, home of the German federal parliament, as people attend a protest rally in front of the Brandenburg Gate in Berlin, Germany, Wednesday, Nov. 18, 2020 against the coronavirus restrictions in Germany. Police in Berlin have requested thousands of reinforcements from other parts of Germany to cope with planned protests by people opposed to coronavirus restrictions. (AP Photo/Michael Sohn)

Police turned water cannon on demonstrators protesting against coronavirus restrictions in the German capital Berlin on Wednesday, television footage showed.

A final analysis of the Phase 3 trial of Pfizer's coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, the company said Wednesday.

It said 162 infections were in people who got placebo, or plain saline, shots, while eight cases were in participants who got the actual vaccine.

Erbil alone recorded 156 cases and nine deaths on Tuesday, the health ministry said.

Japan reported 1,694 new Covid-19 cases for Tuesday, its third highest single-day jump since the pandemic began.

The country's daily new cases dipped below 1,000 for the first time in over a week on Monday, but they rose back up on Tuesday, according to the Health Ministry.

Capital spike: Tokyo reported 493 new Covid-19 infections on Wednesday, the highest daily increase in cases for Japan’s capital since the pandemic began.

“What is going on now that you don’t recognize becomes a case a few weeks later,” he said.

CNN is tracking US cases:

The US Food and Drug Administration (FDA) has issued an emergency use authorization for the first self-test for Covid-19 that can provide rapid results at home.

The Lucira COVID-19 All-In-One Test Kit is a molecular single-use test available by prescription for self-diagnosis of the coronavirus, the agency said Tuesday.

The new test is authorized for people aged 14 and older with suspected Covid-19 and people under 13 when performed by a health care provider.

It is also authorized for use in point-of-care settings, such as doctor’s offices, hospitals, urgent care centers and emergency rooms for all ages but must be collected by a health care provider, the FDA said.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.